IPOs and Secondaries
IPOs and Secondaries Articles
Global Blood Therapeutics shares saw a handy gain in the premarket on Tuesday, despite the company pricing its secondary offering below its previous price level.
Published:
Last Updated:
Selecta Biosciences intends to price more than 4 million shares in the range of $14 to $16 per share for an initial public offering valued up to more than $78 million.
Published:
Last Updated:
Syros Pharmaceuticals expects to price 4 million shares in the range of $14 to $16 per share in an intial public offering valued up to more than $73 million.
Published:
Last Updated:
Acushnet Holdings has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
TPI Composites has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
US Foods has seen its quiet period come to an end, and key analyst calls seen were listed as follows.
Published:
Last Updated:
Two of three initial public offerings (IPOs) scheduled for last week made it out the door, but neither was a huge success. Four more are on the calendar for the coming week, including an IPO a tech...
Published:
Last Updated:
Comtech Telecommunications shares dropped handily in Friday’s session after the company announced the pricing of its secondary offering.
Published:
Last Updated:
Audentes Therapeutics has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Azure Power Global has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
PSAV has lowered its expected price range to $12 to $13 per share from $14 to $17, for more than 14 million shares.
Published:
Last Updated:
Shares of Tonix Pharmaceuticals slid in Thursday’s session after the company announced the pricing of its secondary offering.
Published:
Last Updated:
AdvancePierre Foods has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Zimmer Biomet saw its shares slide in Tuesday's session after the company announced the pricing of its previously disclosed underwritten secondary offering.
Published:
Last Updated:
McGraw-Hill Education has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated: